Application of Magnetic Stealth Liposomes in External Magnetic Field for Gene Therapy -Research for the Clinical Application of New Drug Delivery System-
Application of Magnetic Stealth Liposomes in External Magnetic Field for Gene Therapy -Research for the Clinical Application of New Drug Delivery System-
批准号:
12557124
负责人:
SUGITA Takashi
金额:
$8.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
我们研制了磁性ADR脂质体,该脂质体可以在磁力作用下有效地递送到实体瘤中,并表明静脉给药的磁性ADR脂质体可以有效地递送到植入磁铁的骨肉瘤中。为了临床应用,我们研究了隐身脂质体(磁性ADR - peg -脂质体)的效率和可控制的磁性系统对瘤外磁场的影响,而不是在实体瘤中植入磁铁。此外,我们还开发了磁性阳离子脂质体作为基因治疗的载体,并在体外检测了靶向基因表达的效率。ADR磁性脂质体给药1 h后血液中ADR浓度下降,而ADR peg磁性脂质体给药1 h后血液中ADR浓度相对保持不变。这一结果表明,血液循环潴留将得到改善。肿瘤外磁场对肿瘤的靶向效率低于肿瘤内磁场。我们开发了由DC-chol和DOPE(摩尔比为3:2)组成的磁性阳离子脂质体,并制备了DNA/脂质体复合物。我们使用质粒LacZ作为报告基因。这些复合物在磁力作用下转染到骨肉瘤细胞中。转染后3 h内LacZ的表达水平与未转染时比较,前者较高,但6 h后两者的表达水平基本相等。我们的研究结果表明,聚乙二醇修饰的隐形脂质体可以逃避肝脏库普弗细胞的摄取,该系统可以减少化疗的副作用。对于这种治疗的临床应用,我们认为有必要研究可控磁系统的最佳条件。由于靶细胞周围有高浓度的DNA/脂质体复合物,因此认为磁性阳离子脂质体的基因转染效率更高。
英文摘要
We developed magnetic ADR liposomes which could be effectively delivered to solid tumors under magnetic force and indicated that intravenously administered magnetic ADR liposomes could be used to effectively deliver ADR to osteosarcoma implanted with a magnet. For clinical application of this DDS, we investigated the efficiency of stealth liposomes (magnetic ADR PEG-liposome) and that of magnetic field of extratumor by the controllable magnetic system not by the implantation of a magnet in a solid tumor. Furthermore we also developed magnetic cationic liposomes as a vector for gene therapy, and examined the efficiency of targeting of gene expression in vitro.The concentration of ADR in blood after administration of magnetic ADR liposomes became decreased one hour later, but that of magnetic ADR PEG-liposomes was maintained comparatively. This result demonstrated the retainment in blood circulation would be improved. The magnetic field of extratumor caused the less efficiency of targeting to tumor than that of intratumor. We developed the magnetic cationic liposomes composed of DC-chol and DOPE (3 : 2 by molar ratio) and prepared DNA/liposome complex. We used plasmid LacZ as a reporter gene. These complexes were transfected to osteosarcoma cells under magnetic force. Compared the lebel of LacZ expression with that of under no magnetic force, the former was higher within 3 hours after transfection but the both lebels of 6 hours later were almost equal.Our results suggested that the stealth liposomes by modificated of PEG resulted in the evasion from uptake by Kupffer cells of the liver and this system would reduce side effects of chemotherapy. For the clinical use of this treatment, we thought to have to examine the optimal condition of controllable magnet system. It was considered gene transfection became more efficient by magnetic cationic liposomes according to the high concentration of DNA/liposome complex around the targeted cells.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
平尾 健: "悪性骨・軟部腫瘍に対する遺伝子治療のための磁性体カチオニックリポソームの開発"日整会誌. 75・8. 1083 (2001)
Ken Hirao:“用于恶性骨和软组织肿瘤基因治疗的磁性阳离子脂质体的开发”日精学会杂志75・8(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kubo Tadahiko: "Targeted delivery of anticancer drugs with magnetic liposomes by intravenous administration in osteosarcoma-bearing hamsters."International Journal of Oncology. 17. 309-315 (2000)
Kubo Tadahiko:“通过静脉注射用磁性脂质体向患有骨肉瘤的仓鼠靶向输送抗癌药物。”国际肿瘤学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroo Nobuto: "Targeted Systemic Chemotherapy Using Magnetic Stealth Liposomes with Incorporated Adriamycin for Ostesarcoma in Hamsters"The Journal of the Japanese Orthopaedic Association. Vol.75 (8). 1119 (2001)
Hiroo Nobuto:“使用掺有阿霉素的磁性隐形脂质体进行靶向全身化疗治疗仓鼠骨肉瘤”日本骨科协会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
久保忠彦: "ハムスター骨肉腫に対する静脈内投与による制癌剤封入磁性体リポソームの抗腫瘍効果."Drug Delivery System. 15・4. 343 (2000)
久保忠彦:“静脉注射抗癌药物封装的磁性脂质体对仓鼠骨肉瘤的抗肿瘤作用”15・4(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
延藤 博明: "ハムスターの骨肉腫に対する磁気ターゲッティングを応用した制癌剤/磁性体封入リポソームの開発"日整会誌. 75・8. 1119 (2001)
Hiroaki Nobuto:“利用磁性靶向治疗仓鼠骨肉瘤的抗癌药物/磁性材料封装脂质体的开发”《Nichisai Kaikai》75・8(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Reconstruction of vaginal microbiota to prevent and treat miscarriage and premature birth
-
批准号:25460226
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:SUGITA Takashi
-
依托单位:
Disease control based on analysis of cutaneous microbiota in patients with psoriais
-
批准号:22590150
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:SUGITA Takashi
-
依托单位:
Predictors of the response to therapy targeting the cutaneous microbiota in patient with atpic dermatitis
-
批准号:19590164
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2007
-
负责人:SUGITA Takashi
-
依托单位:
Treatment of atopic dermatitis based on control of microorganisms colonized skin surfface
-
批准号:16590127
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2004
-
负责人:SUGITA Takashi
-
依托单位:
Targetting therapy with liposome encapsulatedanticancerdrugin osteosarcoma on hamsters
-
批准号:08671663
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:SUGITA Takashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
-
批准号:81970829
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:李卓
-
依托单位:
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
-
批准号:81873493
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:沈德良
-
依托单位:
以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
-
批准号:81102033
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:李大森
-
依托单位:
基于ZFN/phiC31系统的新型基因打靶技术的建立(果蝇)
-
批准号:31171278
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:高冠军
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: